Exploring the cross-phenotype network region of disease modules reveals concordant and discordant pathways between chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
Anaplastic Lymphoma Kinase
/ metabolism
Extracellular Matrix
/ metabolism
Female
Gene Regulatory Networks
Genome-Wide Association Study
Glycation End Products, Advanced
/ genetics
Humans
Idiopathic Pulmonary Fibrosis
/ genetics
Lung
/ metabolism
MAP Kinase Signaling System
/ genetics
Male
Phenotype
Pulmonary Disease, Chronic Obstructive
/ genetics
Telomere Homeostasis
/ genetics
Journal
Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958
Informations de publication
Date de publication:
15 07 2019
15 07 2019
Historique:
received:
02
10
2018
revised:
12
03
2019
accepted:
23
03
2019
pubmed:
19
4
2019
medline:
13
3
2020
entrez:
19
4
2019
Statut:
ppublish
Résumé
Chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) are two pathologically distinct chronic lung diseases that are associated with cigarette smoking. Genetic studies have identified shared loci for COPD and IPF, including several loci with opposite directions of effect. The existence of additional shared genetic loci, as well as potential shared pathobiological mechanisms between the two diseases at the molecular level, remains to be explored. Taking a network-based approach, we built disease modules for COPD and IPF using genome-wide association studies-implicated genes. The two disease modules displayed strong disease signals in an independent gene expression data set of COPD and IPF lung tissue and showed statistically significant overlap and network proximity, sharing 19 genes, including ARHGAP12 and BCHE. To uncover pathways at the intersection of COPD and IPF, we developed a metric, NetPathScore, which prioritizes the pathways of a disease by their network overlap with another disease. Applying NetPathScore to the COPD and IPF disease modules enabled the determination of concordant and discordant pathways between these diseases. Concordant pathways between COPD and IPF included extracellular matrix remodeling, Mitogen-activated protein kinase (MAPK) signaling and ALK pathways, whereas discordant pathways included advanced glycosylation end product receptor signaling and telomere maintenance and extension pathways. Overall, our findings reveal shared molecular interaction regions between COPD and IPF and shed light on the congruent and incongruent biological processes lying at the intersection of these two complex diseases.
Identifiants
pubmed: 30997486
pii: 5424998
doi: 10.1093/hmg/ddz069
pmc: PMC6606854
doi:
Substances chimiques
Glycation End Products, Advanced
0
Anaplastic Lymphoma Kinase
EC 2.7.10.1
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
2352-2364Subventions
Organisme : NHLBI NIH HHS
ID : K08 HL136928
Pays : United States
Organisme : NHLBI NIH HHS
ID : P01 HL132825
Pays : United States
Informations de copyright
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Références
Nat Methods. 2013 Dec;10(12):1169-76
pubmed: 24296474
Ann Am Thorac Soc. 2016 Dec;13 Suppl 5:S417-S421
pubmed: 28005427
J Pathol. 2002 Nov;198(3):388-96
pubmed: 12375272
Nat Genet. 2013 Jun;45(6):613-20
pubmed: 23583980
Lancet Respir Med. 2017 Nov;5(11):869-880
pubmed: 29066090
Am J Respir Cell Mol Biol. 2017 Jan;56(1):20-28
pubmed: 27508494
Hum Mol Genet. 2015 Jun 1;24(11):3005-20
pubmed: 25586491
Am J Respir Crit Care Med. 2016 Jul 1;194(1):48-57
pubmed: 26771213
Mol Cell Proteomics. 2013 Nov;12(11):3398-408
pubmed: 23882023
Front Med (Lausanne). 2018 Apr 04;5:87
pubmed: 29670881
Am J Hum Genet. 2008 Apr;82(4):949-58
pubmed: 18371930
Int J Chron Obstruct Pulmon Dis. 2006;1(2):137-50
pubmed: 18046891
Arch Med Sci. 2017 Apr 1;13(3):645-651
pubmed: 28507582
J Clin Invest. 2015 Feb;125(2):563-70
pubmed: 25562321
Eur Respir Rev. 2018 Aug 1;27(149):
pubmed: 30068688
Am J Respir Cell Mol Biol. 2013 Jul;49(1):47-57
pubmed: 23470623
PLoS Genet. 2009 Mar;5(3):e1000421
pubmed: 19300482
J Pathol. 2016 Dec;240(4):397-409
pubmed: 27623753
Am J Respir Cell Mol Biol. 2016 Jun;54(6):751-60
pubmed: 26741177
PLoS One. 2015 Nov 10;10(11):e0142306
pubmed: 26555338
Am J Respir Crit Care Med. 2014 Feb 15;189(4):408-18
pubmed: 24383474
Annu Rev Physiol. 2017 Feb 10;79:517-539
pubmed: 27959617
Elife. 2018 Oct 10;7:
pubmed: 30303482
Proc Natl Acad Sci U S A. 2007 May 1;104(18):7552-7
pubmed: 17460043
Am J Pathol. 2008 Mar;172(3):583-91
pubmed: 18245812
Eur Respir J. 2008 Jan;31(1):62-9
pubmed: 17959643
Am J Physiol Lung Cell Mol Physiol. 2017 Dec 1;313(6):L1164-L1173
pubmed: 28860144
Am J Respir Crit Care Med. 2018 Feb 1;197(3):356-363
pubmed: 28889759
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Nucleic Acids Res. 2016 Jan 4;44(D1):D457-62
pubmed: 26476454
Nat Genet. 2015 May;47(5):512-7
pubmed: 25848748
Am J Respir Crit Care Med. 2015 Sep 1;192(5):559-69
pubmed: 26030696
Hum Mol Genet. 2012 Feb 15;21(4):947-57
pubmed: 22080838
Br J Pharmacol. 2011 May;163(1):141-72
pubmed: 21265830
Nat Genet. 2010 Mar;42(3):200-2
pubmed: 20173748
Database (Oxford). 2015 Apr 15;2015:bav028
pubmed: 25877637
Respir Med. 2011 Mar;105(3):329-36
pubmed: 21112201
Am J Respir Cell Mol Biol. 2015 Feb;52(2):217-31
pubmed: 25029475
Am J Respir Crit Care Med. 2013 Oct 15;188(8):948-57
pubmed: 23947473
PLoS Comput Biol. 2012;8(2):e1002375
pubmed: 22383865
Nat Genet. 2017 Mar;49(3):426-432
pubmed: 28166215
Physiol Rep. 2014 Sep 11;2(9):
pubmed: 25214520
Science. 2015 Feb 20;347(6224):1257601
pubmed: 25700523
Nucleic Acids Res. 2018 Jan 4;46(D1):D649-D655
pubmed: 29145629
Sci Rep. 2018 Sep 27;8(1):14439
pubmed: 30262855
Brief Funct Genomics. 2011 Sep;10(5):280-93
pubmed: 21764832
Lancet Respir Med. 2014 Mar;2(3):214-25
pubmed: 24621683
BioData Min. 2011 Jun 24;4:19
pubmed: 21699738
Lancet Respir Med. 2013 Jun;1(4):309-317
pubmed: 24429156
N Engl J Med. 2011 Apr 21;364(16):1503-12
pubmed: 21506741
Nat Genet. 2019 Mar;51(3):494-505
pubmed: 30804561
Nat Rev Drug Discov. 2012 Oct;11(10):790-811
pubmed: 23000686
Proc Natl Acad Sci U S A. 2007 May 22;104(21):8685-90
pubmed: 17502601